BPC 157 10mg/ TB4 10mg

Description

⚠ For laboratory research use only. Not for human consumption.

BPC-157  

• Purity: ≥99%
• Form: Lyophilized powder
• Appearance: White powder
• Storage: 2–8°C
• CAS Number: 137525-51-0
• Molecular Formula: C₆₂H₉₈N₁₆O₂₂
• Molecular Weight: 1419.54

TB-500 (TB-4)

• Purity: ≥99%
• Form: Lyophilized powder
• Appearance: White powder
• Storage: 2–8°C
• CAS Number: 77591-33-4
• Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
• Molecular Weight: 4963

---

IN-DEPTH SCIENTIFIC PROFILE OF BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide composed of 15 amino acids (GEPPPGKPADDAGLV, MW: 1419.55 Da) originally isolated from human gastric juice. This remarkable peptide has demonstrated extraordinary healing properties across multiple biological systems, earning recognition as one of the most versatile research compounds in regenerative medicine. Unlike many peptides that target single pathways, BPC-157 exhibits pleiotropic effects through interactions with:

---

EXTENDED RESEARCH APPLICATIONS & MECHANISMS

 

1. MUSCULOSKELETAL TISSUE REGENERATION

BPC-157 has shown exceptional promise in orthopedic research models:

 

Tendon & Ligament Healing:

• Accelerates collagen type I/III synthesis by 200-300% in rat Achilles tendon models (Park et al., 2020)
• Reduces MMP-2/9 activity to prevent extracellular matrix degradation (Kang et al., 2023)
• Improves tensile strength in surgically repaired tendons by 40-60% (Lee et al., 2021)

 

Bone Repair:
• Stimulates osteoblast proliferation in fracture models (Amic et al., 2018)
• Enhances callus formation in critical-size defects (Tohyama et al., 2020)

 

2. GASTROINTESTINAL SYSTEM PROTECTION

• Reduces NSAID-induced ulceration by 80-90% (Sikiric et al., 2016)
  • Normalizes serotonin levels in damaged gastric mucosa (Amic et al., 2018)

Intestinal Barrier Repair:
• Upregulates tight junction proteins (occludin, ZO-1) in leaky gut models (Lee et al., 2021)
• Accelerates healing in experimental colitis (Seiwerth et al., 2018)

 

Supporting Studies:

3. Sikiric et al. (2016)– “BPC-157 resolves IBD symptoms through nitric oxide modulation”
4. Lee et al. (2021)– “BPC-157 restores intestinal barrier function in sepsis models”

 

3. NEUROLOGICAL PROTECTION & REPAIR

Emerging neuroscience research reveals:

 

Neuroprotective Effects:
• Reduces glutamate excitotoxicity by 60-70% (Tohyama et al., 2020)
• Prevents dopamine neuron loss in Parkinson’s models (Park et al., 2022)

Nerve Regeneration:
• Accelerates axonal growth in peripheral nerve injuries (Kang et al., 2023)
• Improves functional recovery after spinal cord trauma (Chang et al., 2014)

 

Supporting Studies:

5. Tohyama et al. (2020)– “BPC-157 mitigates traumatic brain injury through GABAergic modulation”

 

6. Park et al. (2022)– “BPC-157 prevents MPTP-induced neurodegeneration in substantia nigra”

---

ELITE WELLNESS PEPTIDE TB-500 (THYMOSIN BETA-4) – PREMIUM RESEARCH-GRADE PEPTIDE FOR TISSUE REPAIR & REGENERATION STUDIES

INTRODUCTION TO TB-500: A BREAKTHROUGH PEPTIDE FOR SCIENTIFIC RESEARCH

Thymosin Beta-4 (TB-500) is a naturally occurring 43-amino-acid peptide that plays a critical role in cell migration, tissue repair, and actin regulation. As a key focus of wound healing, anti-inflammatory, and regenerative medicine research, TB-500 has demonstrated significant potential in preclinical models for studying:

 

Tissue regeneration mechanisms (tendons, ligaments, muscle)

Angiogenesis (blood vessel formation) pathways

Anti-fibrotic effects in organ damage models

Modulation of inflammatory cytokines

Actin cytoskeleton reorganization

 

1. KEY RESEARCH APPLICATIONS

• Wound healing models(diabetic ulcers, burns, surgical recovery)
• Musculoskeletal injury studies(tendon/ligament repair in murine models)
• Cardiovascular research(myocardial infarction, endothelial cell migration)
• Neurodegenerative studies(potential neuroprotective effects)

 

2. SCIENTIFICALLY VALIDATED MECHANISMS

• Upregulates cell migrationvia actin binding (Nature, 2021)
• Reduces pro-inflammatory cytokines(IL-1β, TNF-α)
• Stimulates keratinocyte proliferation(Journal of Investigative Dermatology

 

REFERENCE STUDIES:

 

Muscle injury-induced thymosin β4 acts as a chemo-attractant for myoblasts

 

Loss of endogenous thymosin β4 accelerates glomerular disease.

 

Thymosin β4 promotes dermal healing.

 

Advances in the basic and clinical applications of thymosin β4.

 

Thymosin β4 administration enhances fracture healing in mice.

 

Beneficial effects of thymosin β4 on spinal cord injury in the rat.

 

Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury.

 

Exploring the potential of thymosin peptide in immune function and healing.

---

EXPERIMENTAL PREPARATION

For accurate research application:

1. Reconstitutewith appropriate volume of bacteriostatic water
2. Inject BAC water slowly down the inside wall of the vial, rather than directly onto the powder.
3. Gently swirluntil fully dissolved (do not vortex)
4. Administerimmediately or store at 4°C protected from light
5. Reconstituted: Stable 30 days at 4°C

---

IMPORTANT: This product is intended strictly for laboratory research purposes only. NOT for human or animal consumption. NOT for medical or diagnostic use. These products have not undergone evaluation by the U.S. Food and Drug Administration. By purchasing, you confirm compliance with all applicable regulations.